ForthRight Wealth Management’s AbbVie ABBV Stock Holding History

ForthRight Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-173	Closed	-$19K	–	37
2020 Q4	$19K	Buy	+173	New	+$16.6K	0.01%	96

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ForthRight Wealth Management's ABBV Position: Q1 2021 in Review

ForthRight Wealth Management sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 173 shares — an estimated $19K sold.

ForthRight Wealth Management first reported a position in ABBV in Q4 2020 and held it in 1 quarter. The position peaked at $19K in Q4 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

ForthRight Wealth Management reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
ForthRight Wealth Management sold 173 AbbVie shares in Q1 2021, an estimated $19K.
ForthRight Wealth Management first reported a position in AbbVie in Q4 2020 and held it in 1 quarter.
ForthRight Wealth Management's AbbVie position peaked at $19K in Q4 2020.
2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on ForthRight Wealth Management's 13F filing for Q1 2021, filed 26 Apr 2021.